KPC Pharmaceuticals,Inc. (SHA:600422)

KPC Pharmaceuticals,Inc. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Cash & Equivalents	1,199	2,271	1,500	1,658	1,574	1,485
Trading Asset Securities	1,511	471.28	603.8	319.4	160.5	334.76
Cash & Short-Term Investments	2,711	2,742	2,103	1,978	1,735	1,820
Cash Growth	38.11%	30.36%	6.35%	14.01%	-4.68%	22.80%
Accounts Receivable	3,912	3,855	3,225	2,625	2,011	1,551
Other Receivables	142.36	123.73	797.75	95.1	169.09	150.59
Receivables	4,055	3,979	4,022	2,720	2,180	1,702
Inventory	1,612	1,540	1,772	1,681	1,884	1,718
Other Current Assets	303.63	294.82	250.14	388.21	381.96	320.86
Total Current Assets	8,681	8,555	8,148	6,766	6,180	5,560
Property, Plant & Equipment	1,267	1,286	1,307	1,291	1,361	1,428
Long-Term Investments	90.38	305.46	319.61	320.61	278.24	241.55
Goodwill	1,503	1,503	1,503	91.73	91.73	91.73
Other Intangible Assets	398.48	412.22	441.97	355.98	408.88	369.04
Long-Term Deferred Tax Assets	262.62	258.28	269.12	245.6	233.83	236.74
Long-Term Deferred Charges	242.29	237.84	237	199.07	274.49	247.86
Other Long-Term Assets	259.43	53.12	69.83	161.17	64.98	37.13
Total Assets	12,705	12,611	12,295	9,432	8,893	8,213
Accounts Payable	1,078	1,056	936.78	977.12	1,239	821.45
Accrued Expenses	487.48	1,831	1,597	1,262	1,117	1,137
Short-Term Debt	784.32	658.04	725.49	912.76	641.75	627.81
Current Portion of Long-Term Debt	-	61.05	1	99.5	0.2	0.2
Current Portion of Leases	-	19.28	22.46	22.57	36.07	22.43
Current Income Taxes Payable	-	158.94	149.75	78.76	93.28	78.8
Current Unearned Revenue	53.38	83.32	102.63	186.37	74.09	82.3
Other Current Liabilities	2,348	1,624	329.7	350.01	284.76	379.43
Total Current Liabilities	4,751	5,491	3,865	3,889	3,485	3,149
Long-Term Debt	762.51	46.05	107.56	60	99.5	99.7
Long-Term Leases	47.94	48.59	44.24	44.77	50.47	68.1
Long-Term Unearned Revenue	232.5	229.92	224.09	207.58	245.34	273.58
Long-Term Deferred Tax Liabilities	21.28	21.65	24.28	10.64	15.42	18.39
Other Long-Term Liabilities	28.03	28.03	75.97	77.58	56.67	1.05
Total Liabilities	5,843	5,865	4,341	4,289	3,953	3,610
Common Stock	756.98	756.98	757.99	758.26	758.26	758.26
Additional Paid-In Capital	520.62	520.62	2,327	1,161	1,169	1,163
Retained Earnings	4,072	3,981	3,490	3,071	2,894	2,561
Treasury Stock	-	-	-10.42	-13.15	-26.3	-26.3
Comprehensive Income & Other	-4	-5.29	-1.62	6.3	-11.5	-4.93
Total Common Equity	5,345	5,254	6,562	4,983	4,783	4,451
Minority Interest	1,516	1,493	1,392	159.5	156.98	152
Shareholders' Equity	6,861	6,746	7,954	5,143	4,940	4,603
Total Liabilities & Equity	12,705	12,611	12,295	9,432	8,893	8,213
Total Debt	1,595	833.02	900.74	1,140	828	818.24
Net Cash (Debt)	1,116	1,909	1,203	838.19	906.76	1,002
Net Cash Growth	4.58%	58.73%	43.47%	-7.56%	-9.49%	14.42%
Net Cash Per Share	1.49	2.53	1.58	1.12	1.20	1.32
Filing Date Shares Outstanding	754.02	756.98	757.11	758.13	758.26	758.26
Total Common Shares Outstanding	754.02	756.98	757.99	758.26	758.26	758.26
Working Capital	3,930	3,064	4,283	2,878	2,695	2,411
Book Value Per Share	7.09	6.94	8.66	6.57	6.31	5.87
Tangible Book Value	3,444	3,338	4,617	4,535	4,283	3,990
Tangible Book Value Per Share	4.57	4.41	6.09	5.98	5.65	5.26
Buildings	-	1,325	1,262	1,137	1,136	1,155
Machinery	-	1,058	1,011	988.66	980.07	884.96
Construction In Progress	-	76.46	100.51	64.65	43.51	75.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.